NCT01527994View on ClinicalTrials.gov

Aprepitant Effects in Intravenous Heroin Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

February 28, 2015

Conditions
Opioid Dependence
Interventions
DRUG

Aprepitant

Aprepitant 125 mg oral tablets

DRUG

Placebo pill

Placebo oral pill- inactive compound

Trial Locations (1)

10016

Bellevue Hospital Center & the NYU School of Medicine, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

NYU Langone Health

OTHER

NCT01527994 - Aprepitant Effects in Intravenous Heroin Dependence | Biotech Hunter | Biotech Hunter